前收市價 | 2.0000 |
開市 | 2.0000 |
買盤 | 0.0000 |
賣出價 | 0.0000 |
拍板 | 15.00 |
到期日 | 2026-01-16 |
今日波幅 | 1.9000 - 2.2000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 2.19k |
New data indicate that its cell therapy could soon find a larger market.
Iovance (IOVA) shares updated data from a mid-stage study, which showed that treatment with its combination therapy achieved an objective response rate of 65% in frontline advanced melanoma.
These biotech stocks have just launched their first products.